Recent studies have identified genes involved in resistance to intrace
llular pathogens. Such genes include the murine MHC class I gene, L(d)
(toxoplasmosis), HLA-BW53, HLA DRB1 1302-DQ B10s01 and TNF2 (malaria
), murine Nramp (toxoplasmosis, leishmaniasis and tuberculosis), gene(
s) modulating the T-helper type 1 and type 2 dichotomy (leishmaniasis,
leprosy and HIV infection) and the natural killer cell complex (cytom
egalovirus infection). There also have been other advances in immunoge
netics that have led to a better understanding of resistance to intrac
ellular pathogens. These include effector mechanisms of immune respons
e genes and factors modulating genetic susceptibility. Identification
of genes that determine resistance/susceptibility (and their effector
mechanisms) has impacted on vaccine development. Immunogenetics has be
en important in characterizing roles of TCR genes, superantigens, and
host genes that play a role in molecular mimicry in disease pathogenes
is. In addition, recent work with gene knockout, recombinant inbred or
congenic, mutant, consomic, and transgenic mice, positional cloning,
mouse/human gene homologies to identify candidate human resistance gen
es, and the rapid expansion of the gene transcription maps of the huma
n genome, have been important in analysis of resistance to intracellul
ar pathogens.